MarketCap
Facebook
X
TelegramQuarterly report 2022-Q3
added 11-03-2022
SeaSpine Holdings Corporation Cash Conversion Cycle 2011-2026 | SPNE
Annual Cash Conversion Cycle SeaSpine Holdings Corporation
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 299 | 377 | 307 | 270 | 302 | 301 | 294 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 377 | 270 | 307 |
Quarterly Cash Conversion Cycle SeaSpine Holdings Corporation
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 140 | - | 316 | - | 311 | 300 | 338 | 51.4 | 373 | 467 | 358 | 52 | 308 | 311 | 303 | 48.8 | 267 | 261 | 312 | - | 62.9 | 58.4 | 61.3 | - | 60.3 | 57.7 | 67.3 | - | 70.7 | 69.1 | 67.6 | - | 61.2 | 28.8 | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 467 | 28.8 | 185 |
Cash Conversion Cycle of other stocks in the Medical devices industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Align Technology
ALGN
|
137 | $ 187.53 | 0.54 % | $ 14 B |  USA |
 |
Axonics Modulation Technologies
AXNX
|
299 | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
-81.2 | - | 1.37 % | $ 20.5 M | USA |
 |
Bio-Rad Laboratories
BIO
|
263 | $ 291.34 | -1.6 % | $ 8.22 B | USA |
 |
BioSig Technologies
BSGM
|
607 | - | 37.08 % | $ 85.7 M | USA |
 |
Bruker Corporation
BRKR
|
227 | $ 39.12 | -0.91 % | $ 5.83 K | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
104 | - | - | $ 1.77 B | USA |
 |
Acutus Medical
AFIB
|
761 | - | -26.83 % | $ 2.62 M | USA |
 |
Conformis
CFMS
|
165 | - | - | $ 16.4 M | USA |
 |
Avinger
AVGR
|
335 | - | -20.74 % | $ 369 K | USA |
 |
AdaptHealth Corp.
AHCO
|
20.1 | $ 12.48 | -1.34 % | $ 1.69 B | USA |
 |
Allied Healthcare Products
AHPI
|
271 | - | 3.58 % | $ 2.21 M | USA |
 |
Lianluo Smart Limited
LLIT
|
94.1 | - | 24.59 % | $ 44.8 M |  China |
 |
Obalon Therapeutics, Inc.
OBLN
|
174 | - | -5.86 % | $ 30.6 M | USA |
 |
Cytosorbents Corporation
CTSO
|
104 | $ 0.61 | 3.18 % | $ 38 M | USA |
 |
EDAP TMS S.A.
EDAP
|
163 | $ 3.55 | 0.85 % | $ 133 M |  France |
 |
Boston Scientific Corporation
BSX
|
107 | $ 64.77 | 0.26 % | $ 95.9 B | USA |
 |
Apollo Endosurgery
APEN
|
156 | - | - | $ 475 M | USA |
 |
Cardiovascular Systems
CSII
|
172 | - | 0.15 % | $ 844 M | USA |
 |
Eargo
EAR
|
32.7 | - | - | $ 10.2 M | USA |
 |
ClearPoint Neuro
CLPT
|
217 | $ 10.46 | - | $ 296 M | USA |
 |
Dynatronics Corporation
DYNT
|
80.5 | - | 14.99 % | $ 929 K | USA |
 |
Electromed
ELMD
|
180 | $ 25.88 | 0.66 % | $ 219 M | USA |
 |
Second Sight Medical Products
EYES
|
-29.6 | - | -0.97 % | $ 54.4 M | USA |
 |
CryoLife, Inc.
CRY
|
183 | - | -4.14 % | $ 702 M | USA |
 |
Soliton, Inc.
SOLY
|
-67.9 | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.86 | - | -1.98 % | $ 98.3 M | USA |
 |
GBS
GBS
|
204 | - | -0.57 % | $ 7.12 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-227 | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
28.8 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
81.2 | - | - | $ 111 M |  Canada |
 |
OrthoPediatrics Corp.
KIDS
|
714 | $ 17.49 | -2.04 % | $ 410 M | USA |
 |
Globus Medical
GMED
|
314 | $ 93.94 | -0.62 % | $ 12.7 B | USA |
 |
Helius Medical Technologies
HSDT
|
18.2 | $ 1.92 | -1.03 % | $ 1.17 M | USA |
 |
Butterfly Network
BFLY
|
815 | $ 5.04 | 3.6 % | $ 1.07 B | USA |
 |
Intersect ENT, Inc.
XENT
|
45.4 | - | - | $ 955 M | USA |
 |
Inogen
INGN
|
48.9 | $ 6.2 | - | $ 165 M | USA |
 |
IRIDEX Corporation
IRIX
|
105 | $ 1.02 | -1.92 % | $ 17.3 M | USA |
 |
LENSAR
LNSR
|
85.4 | $ 6.22 | -0.56 % | $ 74.4 M | USA |
 |
BIOLASE
BIOL
|
129 | - | -13.19 % | $ 166 K | USA |
 |
Delcath Systems
DCTH
|
258 | $ 10.76 | -2.09 % | $ 385 M | USA |
 |
Inspire Medical Systems
INSP
|
248 | $ 56.25 | -0.72 % | $ 1.65 B | USA |
 |
CONMED Corporation
CNMD
|
212 | $ 39.15 | -0.79 % | $ 1.22 B | USA |
 |
LivaNova PLC
LIVN
|
113 | $ 65.23 | 0.14 % | $ 3.56 B |  Britain |
 |
Integer Holdings Corporation
ITGR
|
96.8 | $ 87.02 | -0.9 % | $ 3.02 B | USA |
 |
FONAR Corporation
FONR
|
234 | $ 18.8 | 0.16 % | $ 123 M | USA |
 |
Invacare Corporation
IVC
|
214 | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
283 | $ 77.81 | -0.49 % | $ 45.5 B | USA |
 |
Penumbra
PEN
|
352 | $ 332.81 | 0.12 % | $ 13 B | USA |